TYK2 Inhibitors for Treating Autoimmune and Inflammatory Diseases

Ram W Sabnis

doi:10.1021/acsmedchemlett.4c00024

TYK2 Inhibitors for Treating Autoimmune and Inflammatory Diseases

ACS Med Chem Lett. 2024 Feb 6;15(3):320-321. doi: 10.1021/acsmedchemlett.4c00024. eCollection 2024 Mar 14.

Author

Ram W Sabnis¹

Affiliation

¹ Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.

PMID: 38505839
PMCID: PMC10945538 (available on 2025-03-14)
DOI: 10.1021/acsmedchemlett.4c00024

Abstract

Provided herein are novel TYK2 inhibitors, pharmaceutical compositions, use of such compounds in treating autoimmune and inflammatory diseases, and processes for preparing such compounds.

Published 2024 by American Chemical Society.

Publication types

Editorial